Latest Claim Stories

CAMBRIDGE, Mass., March 22, 2013 /PRNewswire-USNewswire/ -- Epizyme, Inc., a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that it has received a Notice of Issuance from the U.S. Patent and Trademark Office (USPTO) for its patent application entitled "ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS", U.S. Patent No.: 8,410,088. The USPTO granted claims covering the novel small...

WILMINGTON, Del., March 20, 2013 /PRNewswire/ -- Butamax(TM) Advanced Biofuels, LLC, the leading biobutanol technology company, announced today it would appeal the Court's claim construction and decisions on certain motions before the Court in Butamax's litigation against Gevo. Paul Beckwith, Butamax Chief Executive Officer, stated, "Butamax has decided to appeal this case immediately. Butamax strongly disagrees with the Court's claim construction. We do not believe it is...

JACKSONVILLE, Fla., Feb. 21, 2013 /PRNewswire/ -- ParkerVision, Inc. (NASDAQ: PRKR) announced today that on February 20, 2013, the United States District Court for the Middle District of Florida issued its patent claim construction ruling, or "Markman Order," in the ongoing patent infringement action between ParkerVision and Qualcomm, Inc. (NASDAQ: QCOM). In a Markman Order, the presiding district court in a patent infringement case sets out the meaning of certain disputed patent...

FORT LAUDERDALE, Fla., Feb. 12, 2013 /PRNewswire/ -- OrbusNeich Medical, Inc. ("OrbusNeich") announced that it received a favorable ruling from the European Patent Office ("EPO") yesterday in connection with its European Patent EP1 341 482. The '482 patent covers certain novel stents with helical structures. It was issued by the EPO to OrbusNeich in October 2010 and does not expire until December 2021. In July 2011, Boston Scientific Corporation (NYSE: BSX) and Terumo Kabushiki...

BARCELONA, Spain, January 29, 2013 /PRNewswire/ -- CLINIPRO, a Spanish company that manufactures medical-aesthetical devices, announces that the Barcelona Trade Court No. 5 has dictated a resolution, dated January 25th, 2013, fully disregarding the lawsuit promoted by Zeltiq Aesthetics Inc. (Nasdaq: ZLTQ) and Massachusetts General Hospital (MGH) against CLINIPRO, for alleged infringements of patents and disloyal competence acts. The matter has been carried out by the SOL...

LeashLocket™ has received notice from the United States Patent and Trademark Office (USPTO) that all twenty-nine of its claims on its revolutionary, collar-mounted, retractable pet leash have been upheld as patentable. A utility patent allows the patent holder to exclude others from making, selling or using the invention for up to twenty years from the filing of the patent application. Denver, CO (PRWEB) January 17, 2013 “First-to-market is an incredible position to be in, but to have...

ARMONK, N.Y., Jan. 10, 2013 /PRNewswire/ -- IBM (NYSE: IBM) today announced that it received a record 6,478 patents in 2012 for inventions that will enable fundamental advancements across key domains including analytics, Big Data, cybersecurity, cloud, mobile, social networking and software defined environments, as well as industry solutions for retail, banking, healthcare, and transportation. These patented inventions also will advance a major shift in computing, known as the era of...

WASHINGTON, Dec. 4, 2012 /PRNewswire/ -- Fish & Richardson today announced that it has won an International Trade Commission (ITC) ruling for Japan-based Mitsubishi Gas Chemical (MGC), one of the world's largest manufacturers of Coenzyme Q10, in a patent infringement case brought by Japanese company Kaneka Corporation. On November 29, 2012, the ITC issued Notice of its Final Determination that MGC does not infringe the patent asserted by Kaneka. Fish senior principal John...

SAN DIEGO, Sept. 17, 2012 /PRNewswire/ -- The following statement is being issued by Robbins Geller Rudman & Dowd, LLP regarding the Yo-Plus® brand yogurt class action in California. LEGAL NOTICE The lawsuit is called Johnson v. General Mills, Inc., Case No. 10-00061, and is in the United States District Court for the Central District of California. On April 20, 2011, the Court entered an order certifying a class action under the California's Unfair Competition Law ("UCL"),...

SAN DIEGO, Sept. 9, 2012 /PRNewswire/ -- The following statement is being issued by Blood Hurst & O'Reardon, LLP regarding the Skechers proposed class action settlement. Legal Notice If you purchased Skechers' footwear called Shape-ups, Resistance Runner, Shape-ups Toners/Trainers, or Tone-ups between August 1, 2008 and August 13, 2012 in the United States, your rights may be affected by a proposed class action settlement. A settlement has been proposed in a class action...